首頁 > 市場調查報告書 > 材料

包裝/容器

市場調查報告書

商品編碼

1424359

軟膠囊市場：按產品類型、按原產地類型、按應用、按最終用戶、按地區

Softgel Capsule Market, By Product Type, By Source Type, By Application, By End User, By Region

出版日期: 2023年12月26日 | 出版商:

Coherent Market Insights | 英文 172 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

軟膠囊的全球市場規模預計將從 2023 年的 69.339 億美元增至 2030 年的 107.406 億美元，預測期內年複合成長率(CAGR)為 6.4%。

報告範圍		報告詳情
基準年	2022年	2023/2024年市場規模	69.339 億美元
實際資料	2018-2021	預測期	2023-2030
預測期間 2023/2024 至 2030/2031 年複合年成長率：	6.40%	2030/2031 年預計金額	107.406 億美元

圖 1. 2023 年軟膠囊全球市場佔有率(%)（按地區）

軟膠囊，也稱為軟膠囊，是一種由軟明膠基材料製成的膠囊，內含液體或半固體填充物。與傳統硬膠囊相比，填充材和明膠殼具有不同的優點。軟膠囊殼比硬膠囊更薄、更彈性，使其能夠以更小的劑型提供更多的填充量，受到消費者的青睞。與硬膠囊相比，明膠材料也加速了殼的溶解，導致攝入後的填充物吸收更快。

軟膠囊有兩種主要類型。第一種類型被包含活性填充劑成分的單一軟明膠殼包圍。第二種是雙壁的，具有防止填充洩漏的內密封層和提供結構完整性的外支撐層。軟膠囊能夠容納液體、固體，甚至乾燥或糊狀填充物，開啟了硬膠囊以外的配方可能性。然而，與硬膠囊相比，生產軟膠囊需要專門的設備和專業知識，這會增加生產成本。明膠殼的穩定性也低於硬膠囊殼，使其更容易受到熱、濕氣和不當儲存條件的影響。

市場動態：.

全球軟膠囊市場主要是由於全球心血管疾病的盛行率不斷上升，這增加了軟膠囊的消費和需求。動脈粥狀硬化和冠狀動脈疾病等各種心血管疾病已成為主要的醫療負擔，特別是在人口老化和生活方式改變的已開發國家。就心臟疾病而言，心血管疾病已成為死亡和長期殘疾的主要原因。例如，2023 年 5 月 15 日，美國疾病管制與預防中心發布的一份美國美國、女性以及大多數種族和民族人民的首要死因；1 10人死於心血管疾病。

此外，2022年11月，加拿大公共衛生局發布的報告發現，心臟病是加拿大第二大死因，每年奪走超過5萬人的生命。

本研究的主要特點

該報告對全球軟膠囊市場進行了詳細分析，並提供了以2022年為基準年的預測期（2023-2030）的市場規模和年複合成長率（CAGR%）。
它還闡明了各個細分市場的潛在商機，並解釋了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球軟膠囊市場的主要企業。
該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球軟膠囊市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過分析全球軟膠囊市場時所使用的各種策略矩陣來促進決策。

北美洲
美國
加拿大
歐洲
德國
英國
西班牙
法國
義大利
俄羅斯
其他歐洲國家
亞太地區
中國
印度
日本
澳洲
韓國
ASEAN
其他亞太地區
拉丁美洲
巴西
阿根廷
墨西哥
其他拉丁美洲
中東
海灣合作理事會國家
以色列
其他中東地區
非洲
北非
中部非洲
南非

第10章競爭形勢

公司簡介
- Catalent, Inc.
- Aenova Group GmbH
- Sirio Pharma Company Ltd
- Captek Softgel International Inc.
- Elnova Pharma
- Fuji Capsule Co., Ltd.
- Capsugel, EuroCaps Ltd
- Guangdong Yichao Biological Co., Ltd.
- Hunan ER-KANG Pharmaceutical Co Ltd
- KD Pharma Group
- United Laboratories
- Soft Gel Technologies, Inc.
- Windzor Pharma Ltd
- ZYUS Life Sciences Inc.
- EuroCaps

第11章章節

參考
調查方法
關於出版商

簡介目錄

Product Code: CMI4265

Global softgel capsule market size is expected to reach US$ 10,740.6 Mn by 2030, from US$ 6,933.9 Mn in 2023, exhibiting a compound annual growth rate (CAGR) of 6.4% during the forecast period.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023/2024:	US$ 6,933.9 Mn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023/2024 to 2030/2031 CAGR:	6.40%	2030/2031 Value Projection:	US$ 10,740.6 Mn

Figure 1. Global Softgel Capsule Market Share (%), By Region, 2023

Softgel capsules which is also known as softgels, are a type of capsule made of a soft, gelatin-based material that envelops a liquid or semi-solid fill. The fill material and gelatin shell offer different advantages over traditional hard capsules. Softgel shells are thinner and more flexible than hard capsules, thereby allowing more fill to be delivered in a smaller dosage form which is appreciated by consumers. The gelatin material also permits faster dissolution of the shell, thus making the fill available for absorption more quickly after ingestion compared to hard capsules.

There are two main types of softgel capsules. The first type is surrounded by a single soft gelatin shell which contains the active fill ingredient. The second type has a dual-layered construction with an inner sealing layer preventing leakage of the fill and an outer support layer providing structural integrity. Softgels are capable of holding liquid, semi-solid and even dry or paste-like fills which opens up formulation possibilities beyond what is offered by hard capsules. However, softgel manufacturing requires specialized equipment and expertise as compared to hard capsules which can increase production costs. Their gelatin-based shell is also less stable than hard capsule shells making them more vulnerable to heat, moisture and improper storage conditions.

Market Dynamics:

Global softgel capsule market is mainly driven by the increasing prevalence of cardiovascular diseases across the world, thus leading to increasing consumption and demand of softgel capsules. Various cardiovascular diseases such as atherosclerosis, coronary artery diseases, and others have become major healthcare burdens, especially in developed nations with aging populations and lifestyle changes. As cardiac associations, cardiovascular diseases have emerged as the leading cause of mortality and long-term disabilities. For instance, on May 15, 2023, according to the report published by the Centers for Disease Control and Prevention, heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the U.S., while one person dies every 33 seconds in the U.S. from cardiovascular disease.

Furthermore, in November 2022, according to the report published by the Public Health Agency in Canada, heart disease is the second leading cause of death in Canada, claiming more than 50,000 lives each year.

Key features of the study:

This report provides in-depth analysis of the global softgel capsule market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global softgel capsule market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Catalent, Inc., Aenova Group GmbH, Sirio Pharma Company Ltd, Captek Softgel International Inc., Elnova Pharma, Fuji Capsule Co., Ltd., Capsugel, EuroCaps Ltd, Guangdong Yichao Biological Co., Ltd., Hunan ER-KANG Pharmaceutical Co Ltd, KD Pharma Group, United Laboratories, Soft Gel Technologies, Inc., Windzor Pharma Ltd , ZYUS Life Sciences Inc. and EuroCaps
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global softgel capsule market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global softgel capsule market

Detailed Segmentation:

Global Softgel Capsule Market, By Product Type
- Gelatin Softgel Capsule
- Non-gelatin Softgel Capsule
Global Softgel Capsule Market, By Source Type
- Animal-based
- Non-animal-based
Global Softgel Capsule Market, By Application
- Anti-inflammatory Drugs
- Antibiotic Drugs
- Cardiovascular Drugs
- Health Supplements
- Others
Global Softgel Capsule Market, By End User
- Pharmaceutical Companies
- Contract Manufacturing Organizations
- Neutraceuticals Companies
- Others
Global Softgel Capsule Market, By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Top Companies in the Global Softgel Capsule Market:
- Catalent, Inc.
- Aenova Group GmbH
- Sirio Pharma Company Ltd
- Captek Softgel International Inc.
- Elnova Pharma
- Fuji Capsule Co., Ltd.
- Capsugel, EuroCaps Ltd
- Guangdong Yichao Biological Co., Ltd.
- Hunan ER-KANG Pharmaceutical Co Ltd
- KD Pharma Group
- United Laboratories
- Soft Gel Technologies, Inc.
- Windzor Pharma Ltd
- ZYUS Life Sciences Inc.
- EuroCaps

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Softgel Capsule Market, By Product Type
- Global Softgel Capsule Market, By Source Type
- Global Softgel Capsule Market, By Application
- Global Softgel Capsule Market, By End User
- Global Softgel Capsule Market, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Rising global nutraceuticals industry
- High production cost associated with softgel capsules
- Emerging markets in Asia Pacific and Latin America
Key Highlights
Regulatory Scenario
Recent Trends
PEST Analysis
PORTER's Analysis
Mergers, Acquisitions, and Collaborations

4. Global Softgel Capsule Market- Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Softgel Capsule Market, By Product Type, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Gelatin Softgel Capsule
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Non-gelatin Softgel Capsule
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

6. Global Softgel Capsule Market, By Source Type, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Animal-based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Non-animal-based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

7. Global Softgel Capsule Market, By Application, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Anti-inflammatory Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Antibiotic Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Cardiovascular Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Health Supplements
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

8. Global Softgel Capsule Market, By End User, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Contract Manufacturing Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Neutraceuticals Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

9. Global Softgel Capsule Market, By Region, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2019 -2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
GCC Countries
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Mn)
North Africa
Central Africa
South Africa

10. Competitive Landscape

Company Profile
- Catalent, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Aenova Group GmbH
- Sirio Pharma Company Ltd
- Captek Softgel International Inc.
- Elnova Pharma
- Fuji Capsule Co., Ltd.
- Capsugel, EuroCaps Ltd
- Guangdong Yichao Biological Co., Ltd.
- Hunan ER-KANG Pharmaceutical Co Ltd
- KD Pharma Group
- United Laboratories
- Soft Gel Technologies, Inc.
- Windzor Pharma Ltd
- ZYUS Life Sciences Inc.
- EuroCaps
Analyst Views